• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植后急性移植物抗宿主病危险因素的评估:一项基于比例优势模型并使用非线性混合效应模型的回顾性研究

Assessment of risk factors for acute graft--host disease post-hematopoietic stem cell transplantation: a retrospective study based on a proportional odds model using a nonlinear mixed-effects model.

作者信息

Xue Ling, Song Lin, Yu Xun, Yang Xiao, Xia Fan, Ding Xiaoliang, Huang Chenrong, Wu Depei, Miao Liyan

机构信息

Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Pharmacology, Faculty of Medicine, University of the Basque Country - (UPV/EHU), Leioa, Spain.

出版信息

Ther Adv Hematol. 2023 Oct 21;14:20406207231205406. doi: 10.1177/20406207231205406. eCollection 2023.

DOI:10.1177/20406207231205406
PMID:37872970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10590544/
Abstract

BACKGROUND

Acute graft--host disease (aGVHD) is a major complication following hematopoietic stem cell transplantation (HSCT).

OBJECTIVE

This study aimed to explore the risk factors for the incidence of aGVHD in patients post-HSCT.

DESIGN

This was a retrospective study.

METHODS

A total of 407 patients were enrolled. The patients' data were recorded from the medical records. The exposure of cyclosporine was estimated based on a population pharmacokinetics model. The occurrence of aGVHD was clinically graded and staged in severity from grades I to IV. A proportional odds model that estimated the cumulative probabilities of aGVHD was used to analyze the data using a nonlinear mixed-effects model. Then, the model parameters and plausibility were evaluated by bootstrap and visual predictive checks.

RESULTS

The typical probabilities were 18.9% and 17.9% for grade II and grades III-IV, respectively. The incidence of grade II and grade III-IV aGVHD for human leukocyte antigen (HLA) haplo sibling donor patients was higher than that for HLA-matched donor patients. The incidence of grade II and grade III-IV aGVHD decreased with increasing early cyclosporine trough concentration; however, cyclosporine exposure was not associated with the incidence of aGVHD.

CONCLUSION

HLA matching and early cyclosporine trough concentration were important factors for the occurrence of aGVHD.

摘要

背景

急性移植物抗宿主病(aGVHD)是造血干细胞移植(HSCT)后的主要并发症。

目的

本研究旨在探讨HSCT术后患者发生aGVHD的危险因素。

设计

这是一项回顾性研究。

方法

共纳入407例患者。从病历中记录患者的数据。基于群体药代动力学模型估算环孢素的暴露量。aGVHD的发生根据临床分级和严重程度分为I至IV级。使用估计aGVHD累积概率的比例优势模型,通过非线性混合效应模型分析数据。然后,通过自抽样法和可视化预测检验评估模型参数和合理性。

结果

II级和III-IV级的典型概率分别为18.9%和17.9%。人类白细胞抗原(HLA)单倍体同胞供者患者的II级和III-IV级aGVHD发生率高于HLA匹配供者患者。II级和III-IV级aGVHD的发生率随早期环孢素谷浓度的升高而降低;然而,环孢素暴露与aGVHD的发生率无关。

结论

HLA匹配和早期环孢素谷浓度是发生aGVHD的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/0135aff3ebab/10.1177_20406207231205406-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/919d0d1e1d09/10.1177_20406207231205406-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/ed482b57b642/10.1177_20406207231205406-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/7e614a22a30d/10.1177_20406207231205406-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/0135aff3ebab/10.1177_20406207231205406-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/919d0d1e1d09/10.1177_20406207231205406-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/ed482b57b642/10.1177_20406207231205406-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/7e614a22a30d/10.1177_20406207231205406-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/439d/10590544/0135aff3ebab/10.1177_20406207231205406-fig4.jpg

相似文献

1
Assessment of risk factors for acute graft--host disease post-hematopoietic stem cell transplantation: a retrospective study based on a proportional odds model using a nonlinear mixed-effects model.造血干细胞移植后急性移植物抗宿主病危险因素的评估:一项基于比例优势模型并使用非线性混合效应模型的回顾性研究
Ther Adv Hematol. 2023 Oct 21;14:20406207231205406. doi: 10.1177/20406207231205406. eCollection 2023.
2
[Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].单倍型人类白细胞抗原配型造血干细胞移植治疗恶性血液病的临床研究
Ai Zheng. 2006 Aug;25(8):1019-22.
3
[Clinical characteristics of acute graft-versus-host disease among different donors of allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植不同供者急性移植物抗宿主病的临床特征]
Zhonghua Xue Ye Xue Za Zhi. 2010 Nov;31(11):732-5.
4
Premature cyclosporine cessation and TBI-containing conditioning regimen increase the risk of acute GvHD in children undergoing unrelated donor hematopoietic stem cell transplantation.过早停用环孢素以及含全身照射的预处理方案会增加接受非血缘供者造血干细胞移植儿童发生急性移植物抗宿主病的风险。
Adv Clin Exp Med. 2019 Sep;28(9):1185-1192. doi: 10.17219/acem/103069.
5
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.环孢素 A 浓度对单倍体造血细胞移植后急性移植物抗宿主病发生率的影响。
Eur J Haematol. 2019 Jul;103(1):10-17. doi: 10.1111/ejh.13233. Epub 2019 May 14.
6
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.环孢素 A 浓度对异基因造血干细胞移植后严重急性移植物抗宿主病发生率的影响。
Biol Blood Marrow Transplant. 2010 Jan;16(1):28-34. doi: 10.1016/j.bbmt.2009.08.010. Epub 2009 Oct 1.
7
Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study.接受异基因造血干细胞移植的成年患者的结膜急性移植物抗宿主病:一项队列研究。
PLoS One. 2016 Nov 30;11(11):e0167129. doi: 10.1371/journal.pone.0167129. eCollection 2016.
8
Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation.人类白细胞抗原基因座和单倍型对人类白细胞抗原匹配的同胞外周血干细胞移植后肠道急性移植物抗宿主病的影响。
Chin Med J (Engl). 2017 Jun 5;130(11):1290-1295. doi: 10.4103/0366-6999.206356.
9
Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience.异基因造血干细胞移植后急性移植物抗宿主病的危险因素:单中心经验
Ann Transplant. 2017 Feb 3;22:58-65. doi: 10.12659/aot.901495.
10
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.脐带血和匹配同胞供者异基因造血细胞移植后急性和慢性移植物抗宿主病的危险因素
Biol Blood Marrow Transplant. 2016 Jan;22(1):134-40. doi: 10.1016/j.bbmt.2015.09.008. Epub 2015 Sep 11.

引用本文的文献

1
Real-world safety and effectiveness of alemtuzumab as a conditioning regimen for hematopoietic stem cell transplantation.阿仑单抗作为造血干细胞移植预处理方案的真实世界安全性和有效性
Int J Hematol. 2025 Jul 7. doi: 10.1007/s12185-025-04033-w.

本文引用的文献

1
Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.环孢素在异基因造血干细胞移植受者中的群体药代动力学:C反应蛋白作为清除率的新协变量
J Clin Pharm Ther. 2022 Apr;47(4):483-492. doi: 10.1111/jcpt.13569. Epub 2021 Nov 14.
2
An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation.一种用于预测异基因造血干细胞移植后急性移植物抗宿主病(aGvHD)的智能临床决策支持系统。
J Biomed Phys Eng. 2021 Jun 1;11(3):345-356. doi: 10.31661/jbpe.v0i0.2012-1244. eCollection 2021 Jun.
3
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft-vs-host disease-a retrospective study.
异基因骨髓移植后中性粒细胞急剧恢复是急性移植物抗宿主病发展的一个主要危险因素:一项回顾性研究。
Transpl Int. 2020 Dec;33(12):1723-1731. doi: 10.1111/tri.13741. Epub 2020 Sep 28.
4
Predicting Acute Graft-Versus-Host Disease Using Machine Learning and Longitudinal Vital Sign Data From Electronic Health Records.使用机器学习和电子健康记录中的纵向生命体征数据预测急性移植物抗宿主病。
JCO Clin Cancer Inform. 2020 Feb;4:128-135. doi: 10.1200/CCI.19.00105.
5
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.基于多中心的造血干细胞移植患者环孢素群体药代动力学分析。
Pharm Res. 2019 Dec 23;37(1):15. doi: 10.1007/s11095-019-2740-2.
6
Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation.使用机器学习算法预测异基因移植后急性移植物抗宿主病。
Blood Adv. 2019 Nov 26;3(22):3626-3634. doi: 10.1182/bloodadvances.2019000934.
7
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.中国接受造血干细胞移植的儿童环孢素的群体药代动力学。
Acta Pharmacol Sin. 2019 Dec;40(12):1603-1610. doi: 10.1038/s41401-019-0277-x. Epub 2019 Jul 24.
8
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.环孢素 A 浓度对单倍体造血细胞移植后急性移植物抗宿主病发生率的影响。
Eur J Haematol. 2019 Jul;103(1):10-17. doi: 10.1111/ejh.13233. Epub 2019 May 14.
9
Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study.造血干细胞移植患儿中环孢素曲线下面积与急性移植物抗宿主病的关系:一项前瞻性多中心研究。
Pediatr Hematol Oncol. 2018 May;35(4):288-296. doi: 10.1080/08880018.2018.1520948. Epub 2018 Dec 28.
10
Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.造血细胞移植后急性移植物抗宿主病绝对风险的预测
PLoS One. 2018 Jan 18;13(1):e0190610. doi: 10.1371/journal.pone.0190610. eCollection 2018.